Moleculin Biotech, Inc., (Moleculin or the Company), a late stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced the ...

WASHINGTON, DC—A sirolimus drug-coated balloon (DCB) is noninferior to paclitaxel-coated DCBs for the treatment of femoropopliteal artery disease, according to data from the SIRONA trial, the first ...

Sirolimus-coated balloons were noninferior to paclitaxel-coated balloons in terms of safety and efficacy in treating patients with femoropopliteal artery disease, based on findings from the ...

The company is preparing to launch an early feasibility study in the US to further evaluate the treatment for coronary lesions.

“paclitaxel for injection (Albumin Bound),” “paclitaxel protein-bound particles,” “albumin-bound paclitaxel,” and its brand name, “Abraxane”. To ensure accuracy in our findings, we performed ...

The first approval is for use with carboplatin and paclitaxel as a first-line treatment for adults with primary advanced or recurrent endometrial carcinoma who are eligible for systemic therapy. The ...

Participants in both cohorts will be followed for five years. The paclitaxel-coated Prevail was previously launched in Europe in 2021, and the company said it is commercially available in 79 ...

After getting a biopsy, they confirmed that it was cancer – Stage 1, Grade 3. The stage means how severe the cancer is. So, Stage 1 is the best-case scenario. Grade 3 is how quickly it's spreading, so ...

During this procedure, the balloon inflates within the artery while delivering the paclitaxel drug to the ... a GlobalData owned brand. The information on this site has been included in good ...

Since then, I’ve had eight rounds of chemotherapy. The first four rounds were a drug called the EC drug (Epirubicin Cyclophosphamide), and then the last four rounds were a drug called Paclitaxel [both ...